Cargando…
MiRNA-223-3p Affects Mantle Cell Lymphoma Development by Regulating the CHUK/NF-ƘB2 Signaling Pathway
BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive malignancy that accounts for 5–10% of non-Hodgkin’s lymphoma. MiRNA-223-3p has been demonstrated to be down-regulated in MCL and is a useful prognostic factor. However, little is known about underlying molecular mechanism of miRNA-233-3p in MCL...
Autores principales: | Yuan, Jingjing, Zhang, Qing, Wu, Shengsheng, Yan, Suran, Zhao, Ran, Sun, Yajuan, Tian, Xiaoxu, Zhou, Keshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936672/ https://www.ncbi.nlm.nih.gov/pubmed/33688203 http://dx.doi.org/10.2147/OTT.S283486 |
Ejemplares similares
-
Chuk y Guek
por: Gaidar, Arkadi, 1904-1941
Publicado: (1954) -
Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis
por: Li, Xin, et al.
Publicado: (2021) -
Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
por: He, Jianxia, et al.
Publicado: (2021) -
miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016) -
Associations of miRNA-146a and miRNA-223 with Rheumatoid Arthritis and Their Predictive Values
por: Zhang, Haoshaqiang, et al.
Publicado: (2023)